131 related articles for article (PubMed ID: 25005268)
1. Photodynamic therapy downregulates the function of regulatory T cells in patients with esophageal squamous cell carcinoma.
Reginato E; Lindenmann J; Langner C; Schweintzger N; Bambach I; Smolle-Jüttner F; Wolf P
Photochem Photobiol Sci; 2014 Sep; 13(9):1281-9. PubMed ID: 25005268
[TBL] [Abstract][Full Text] [Related]
2. The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells.
Yang PW; Chiang TH; Hsieh CY; Huang YC; Wong LF; Hung MC; Tsai JC; Lee JM
Lasers Med Sci; 2015 Dec; 30(9):2353-61. PubMed ID: 26450615
[TBL] [Abstract][Full Text] [Related]
3. Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
Hatogai K; Yano T; Kojima T; Onozawa M; Daiko H; Nomura S; Yoda Y; Doi T; Kaneko K; Ohtsu A
Gastrointest Endosc; 2016 Jun; 83(6):1130-1139.e3. PubMed ID: 26608125
[TBL] [Abstract][Full Text] [Related]
4. The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.
Yang PW; Hung MC; Hsieh CY; Tung EC; Wang YH; Tsai JC; Lee JM
Lasers Med Sci; 2013 Feb; 28(2):605-14. PubMed ID: 22585382
[TBL] [Abstract][Full Text] [Related]
5. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
Yano T; Muto M; Minashi K; Onozawa M; Nihei K; Ishikura S; Kaneko K; Ohtsu A
Endoscopy; 2011 Aug; 43(8):657-63. PubMed ID: 21623555
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: a phase II study.
Yano T; Muto M; Minashi K; Iwasaki J; Kojima T; Fuse N; Doi T; Kaneko K; Ohtsu A
Int J Cancer; 2012 Sep; 131(5):1228-34. PubMed ID: 22024814
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the CD4+CD25high regulatory T cells and the outcome of chemotherapy in advanced esophageal carcinoma.
Wang G; Sun Y; Ji C; He Y; Hu C; Jiang F; Chen M; Duan Q; Fan P; Hu B
Hepatogastroenterology; 2013 Jun; 60(124):704-8. PubMed ID: 23262265
[TBL] [Abstract][Full Text] [Related]
9. Preclinical validation of talaporfin sodium-mediated photodynamic therapy for esophageal squamous cell carcinoma.
Ohashi S; Kikuchi O; Tsurumaki M; Nakai Y; Kasai H; Horimatsu T; Miyamoto S; Shimizu A; Chiba T; Muto M
PLoS One; 2014; 9(8):e103126. PubMed ID: 25090101
[TBL] [Abstract][Full Text] [Related]
10. Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer.
Theodoraki MN; Lorenz K; Lotfi R; Fürst D; Tsamadou C; Jaekle S; Mytilineos J; Brunner C; Theodorakis J; Hoffmann TK; Laban S; Schuler PJ
Photodiagnosis Photodyn Ther; 2017 Sep; 19():194-201. PubMed ID: 28578124
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of early squamous cell cancers of the esophagus.
Radu A; Wagnières G; van den Bergh H; Monnier P
Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):439-60. PubMed ID: 10900053
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy.
Heier SK; Rothman KA; Heier LM; Rosenthal WS
Gastroenterology; 1995 Jul; 109(1):63-72. PubMed ID: 7541003
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus.
Tanaka T; Matono S; Nagano T; Murata K; Sueyoshi S; Yamana H; Shirouzu K; Fujita H
Gastrointest Endosc; 2011 Jan; 73(1):1-6. PubMed ID: 21074765
[TBL] [Abstract][Full Text] [Related]
14. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
Wang ZH; Zhu JY; Li T; Leng XS
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of photodynamic therapy in esophageal squamous cell carcinoma.
Yi E; Yang CK; Leem C; Park Y; Chang JE; Cho S; Jheon S
J Photochem Photobiol B; 2014 Dec; 141():20-5. PubMed ID: 25313538
[TBL] [Abstract][Full Text] [Related]
16. CD4 + CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy.
Xu T; Duan Q; Wang G; Hu B
Cell Biochem Biophys; 2011 Nov; 61(2):389-92. PubMed ID: 21607687
[TBL] [Abstract][Full Text] [Related]
17. Predictive factor for photodynamic therapy effects on oral squamous cell carcinoma and oral epithelial dysplasia.
Uehara M; Ikeda H; Nonaka M; Sumita Y; Nanashima A; Nonaka T; Asahina I
Arch Oral Biol; 2011 Nov; 56(11):1366-72. PubMed ID: 21596370
[TBL] [Abstract][Full Text] [Related]
18. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
[TBL] [Abstract][Full Text] [Related]
19. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
20. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy.
Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY
Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
